SELLAS Life Sciences (SLS) Revenue (2012 - 2022)

SELLAS Life Sciences (SLS) has 7 years of Revenue data on file, last reported at $1.0 million in Q1 2022.

• On a quarterly basis, Revenue fell 82.46% year-over-year to $1.0 million in Q1 2022; TTM through Dec 2022 was $1.0 million, a 86.84% decrease from a year earlier, with the FY2022 full-year figure at $1.0 million, down 86.84% from the prior year.
• Revenue for Q1 2022 stood at $1.0 million, down from $1.9 million in the prior quarter.
• Over the last five years, Revenue for SLS reached as high as $5.7 million in Q1 2021 and fell as low as $1.0 million in Q1 2022.
• Historically, Revenue has averaged $2.6 million across 3 years, with a median of $1.9 million in 2020.
• On a YoY basis, Revenue climbed as much as 82.46% in 2022 and fell as far as 82.46% in 2022.
• Year by year, Revenue stood at $1.9 million in 2020, then changed by 0.0% to $1.9 million in 2021, then slumped by 47.37% to $1.0 million in 2022.
• Per Business Quant data, the three most recent Revenue figures were $1.0 million in Q1 2022, $1.9 million in Q2 2021, and $5.7 million in Q1 2021.